MDCX Medicus Pharma Ltd.

Fundamentals / CIK 0001997296 / USD
Other share classes on CIK 0001997296: MDCXW

Medicus Pharma Ltd. reported $14.54M in total assets and a net loss of $50.91M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MDCX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$44.21MFY 2023 Net Income: -$5.31M2023FY 2024 Net Income: -$11.16M2024FY 2025 Net Income: -$47.28M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $7.72M $3.53M $194K
Total Operating Expenses $34.36M $11.18M $4.73M
Operating Income -$34.36M -$11.18M -$4.73M
Income Tax Expense $0 $0 $0
Net Income -$47.28M -$11.16M -$5.31M
Basic EPS -$137.00 -$58.00 -$76.50
Diluted EPS -$137.00 -$58.00 -$76.50
Basic Shares Outstanding 345.7K 192.4K 69.6K
Diluted Shares Outstanding 345.7K 192.4K 69.6K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.95M $4.91M $2.70M $2.59M $1.68M $1.44M $2.01M $1.37M
Total Operating Expenses $14.46M $11.48M $8.60M $7.79M $15.43M $6.02M $5.13M $3.59M
Operating Income -$14.46M -$11.48M -$8.60M -$7.79M -$15.43M -$6.02M -$5.13M -$3.59M
Interest Expense -- $206K $375K -- -- $0 $0 --
Net Income -$15.18M -$11.62M -$9.04M -$15.07M -$20.94M -$6.18M -$5.10M -$3.54M
Basic EPS -$11.64 -$10.50 -$15.50 -- -$56.18 -$21.50 -$21.00 --
Diluted EPS -$11.64 -$10.50 -$15.50 -- -$56.18 -$21.50 -$21.00 --
Basic Shares Outstanding 1.3M 1.1M 590.8K -- 372.6K 285.7K 244.8K --
Diluted Shares Outstanding 1.3M 1.1M 590.8K -- 372.6K 285.7K 244.8K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $8.71M $4.16M $1.72M
Cash & Short-Term Investments $8.71M $4.16M $1.72M
Total Current Assets $9.89M $5.38M $1.89M
Total Non-Current Assets $171K $269K $0
Total Assets $10.06M $5.65M $1.89M
Accounts Payable $3.44M $1.28M $211K
Short-Term Debt $5.25M $0 --
Total Current Liabilities $9.94M $2.31M $782K
Total Non-Current Liabilities $86K $206K $0
Total Liabilities $10.02M $2.51M $782K
Total Debt (incl. Leases) $5.45M $322K --
Common Stock $57.08M $30.52M $18.76M
Retained Earnings -$64.35M -$28.90M -$17.75M
Accumulated Other Comp. Income $11K $0 --
Total Stockholders' Equity -$68K $3.13M --
Total Equity $37K $3.13M $1.11M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $5.02M $15.17M $6.37M $8.71M $8.66M $9.67M $3.98M $4.16M
Cash & Short-Term Investments $5.02M $15.17M $6.37M $8.71M $8.66M $9.67M $3.98M $4.16M
Total Current Assets $6.37M $16.98M $7.28M $9.89M $9.78M $11.00M $5.09M $5.38M
Total Non-Current Assets $8.16M $10.13M $144K $171K $196K $938K $570K $269K
Total Assets $14.54M $27.12M $7.43M $10.06M $9.98M $11.93M $5.66M $5.65M
Accounts Payable $2.13M $6.73M $2.28M $3.44M $2.03M $1.77M $2.04M $1.28M
Short-Term Debt -- -- $2.34M $5.25M $6.79M $4.70M -- $0
Total Current Liabilities $9.74M $10.84M $5.95M $9.94M $10.66M $8.54M $3.34M $2.31M
Total Non-Current Liabilities $15.28M $18.00M $45K $86K $125K $142K $174K $206K
Total Liabilities $25.03M $28.84M $6.00M $10.02M $10.78M $8.69M $3.51M $2.51M
Total Debt (incl. Leases) $108K $137K $2.52M $5.45M $7.02M $4.97M $295K $322K
Common Stock $80.60M $74.30M $67.11M $57.08M $4 $37.83M $32.91M $30.52M
Retained Earnings -$100.2M -$85.01M -$73.39M -$64.35M -$5 -$40.18M -$34.01M -$28.90M
Accumulated Other Comp. Income $40K $61K -$191K $11K $11K -- -- $0
Total Stockholders' Equity -$10.54M -$1.76M $1.33M -$68K -$910K -- -- $3.13M
Total Equity -$10.49M -$1.72M $1.43M $37K -$805K $3.25M $2.15M $3.13M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$35.44M -$11.16M -$5.31M
Stock-Based Compensation $1.51M $713K $99K
Change in Payables $924K $809K $79K
Operating Cash Flow -$22.78M -$10.25M -$4.16M
Investing Cash Flow -$4.62M $0 --
Common Stock Issued $9.79M $5.47M $0
Financing Cash Flow $31.94M $12.69M $5.61M
Net Change in Cash $4.54M $2.44M $1.45M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$15.17M -$11.68M -$9.04M -$8.18M -$15.98M -$6.18M -$5.10M -$3.54M
Stock-Based Compensation $132K $1.41M $599K $430K $853K $117K $112K $92K
Change in Payables -$4.56M $4.41M -$1.26M $1.30M -$785K -$251K $656K --
Operating Cash Flow -$15.94M -$6.98M -$8.97M -$6.61M -$6.76M -$5.47M -$3.94M -$3.19M
Common Stock Issued $0 $0 $0 $0 $0 $6.01M $3.78M --
Financing Cash Flow $3.89M $25.53M $6.83M $6.65M $10.37M $11.16M $3.76M $2.05M
Net Change in Cash -$12.10M $18.83M -$2.34M $43K -$1.01M $5.69M -$182K --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- -355.9% --
Return on Assets (ROA) -469.9% -197.6% -280.8%
Current Ratio 1.00x 2.33x 2.42x
Quick Ratio 0.88x 1.81x 2.20x
Debt to Equity -- 0.10x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -3862.7% -- -- -- -- -355.9%
Return on Assets (ROA) -350.2% -209.0% -689.7% -469.9% -358.3% -143.2% -257.2% -197.6%
Current Ratio 0.65x 1.57x 1.22x 1.00x 0.92x 1.29x 1.53x 2.33x
Quick Ratio 0.52x 1.40x 1.07x 0.88x 0.81x 1.13x 1.19x 1.81x
Debt to Equity -- -- 1.90x -- -- -- -- 0.10x
Source: SEC EDGAR CompanyFacts (CIK 0001997296) · from December 31, 2023 Data through September 30, 2026 · synced Nov 21, 2026, 05:11 UTC · Open in terminal